Announced Wed, 24 Sept · 22:50 IST

Niva Bupa Health Insurance Company Limited has informed the Exchange regarding receipt of IRDAI approval on September 24, 2025 for the appointment of Mr. Milind Gajanan Barve (DIN: 00087839) as the Chairman of the Board of Directors with effect from August 28, 2025.

NIVABUPA · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close
-0.7%1-day move
₹81.05
prior close
₹82.00
base price
After-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
-0.6-0.5-0.9-0.8-0.7+2.6+1.1+1.2+0.0-1.7-6.4-7.6-6.2-6.7
Up moveDown movePending
AI summary

Niva Bupa Health Insurance has received approval from the insurance regulator IRDAI for the appointment of Mr. Milind Gajanan Barve (DIN: 00087839) as the Chairman of its Board of Directors. The appointment is effective from August 28, 2025, with the regulatory approval granted on September 24, 2025. This is a routine disclosure under SEBI Listing Regulations, confirming regulatory clearance for the board leadership position. Mr. Barve is a seasoned financial services professional known for his long tenure at HDFC Asset Management.

Likely market impact

This formalises and validates the company's board leadership, which is generally seen as a positive governance signal for shareholders. With regulatory approval secured, investors can expect greater continuity and strategic direction at the board level.